Somewhat Favorable News Coverage Somewhat Unlikely to Affect Balchem (BCPC) Share Price
News articles about Balchem (NASDAQ:BCPC) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Balchem earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave news stories about the basic materials company an impact score of 47.1278517086157 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Shares of Balchem (NASDAQ BCPC) opened at $87.71 on Thursday. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. The firm has a market cap of $2,800.00, a P/E ratio of 34.24 and a beta of 1.09. Balchem has a fifty-two week low of $71.95 and a fifty-two week high of $89.50.
Balchem (NASDAQ:BCPC) last issued its quarterly earnings results on Tuesday, November 7th. The basic materials company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.01. The business had revenue of $150.72 million during the quarter. Balchem had a net margin of 11.11% and a return on equity of 14.68%.
COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Balchem (BCPC) Share Price” was reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/29/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-balchem-bcpc-share-price.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.